Ambulance blood test could speed up stroke care

NCT ID NCT07231315

Not yet recruiting Diagnosis Sponsor: The George Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a rapid blood test (GFAP) that paramedics can use in ambulances to quickly identify if a stroke patient has a brain bleed. The test aims to help doctors decide the best treatment faster. About 465 adults with stroke symptoms will be enrolled within 3 hours of symptom onset.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LVOne rapid blood test (GFAP measurement)
What this could lead to: If successful, this could allow paramedics to quickly identify brain bleeding in stroke patients, leading to faster and more targeted treatment.
What could go wrong: This is an early validation study, so the test may not be accurate enough in real-world settings. It only measures one type of stroke and may miss other causes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HEMORRHAGE

Contacts and locations

Locations

Liverpool Hospital

Sydney, New South Wales, Australia
Nepean Hospital

Sydney, New South Wales, Australia
New South Wales Ambulance

Sydney, New South Wales, Australia
Royal North Shore Hospital

Sydney, New South Wales, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.